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The remarkable resistance of the urinary tract
to infection has been attributed to its physical
properties and the innate immune responses
triggered by pattern recognition receptors
such as TLRs. We report a distinct TLR4-
mediated mechanism in bladder epithelial cells
(BECs) that abrogates bacterial invasion, a nec-
essary step for successful infection. Compared
to controls, uropathogenic type 1 fimbriated
Escherichia coli and Klebsiella pneumoniae in-
vaded BECs of TLR4 mutant mice in 10-fold or
greater numbers. TLR4-mediated suppression
of bacterial invasion was linked to increased
intracellular cAMP levels, which negatively
impacted Rac-1-mediated mobilization of the
cytoskeleton, a critical step in bacterial invasion.
Artificially increasing intracellular cAMP levels
in BECs of TLR4 mutant mice restored resis-
tance to type 1 fimbriated bacterial invasion.
These findings reveal that in addition to their
well known function in cytokine signaling, TLRs
mediate proximal signaling events to actively
inhibit bacterial invasion in the bladder.
INTRODUCTION
In spite of its close proximity to the gastrointestinal tract
which harbors a large reservoir of, primarily, Gram-
negative bacteria with the potential to cause infections,
the urinary tract remains refractile to infection. Much of
this resistance is attributable to the mechanical forces
existing in the urinary tract and to the ability of the epithelial
cells lining the tract to recognize incoming bacteria and
to mount a rapid and effective immune response (Mulvey
et al., 2000; Reid and Sobel, 1987).
The bladder, which comprises a major portion of the
lower urinary tract, is a specialized structure employed
for the storage of urine. Because of this role, the superficial
BECs intrinsically are highly impermeable to pathogens
(Truschel et al., 2002). On the apical surfaces of BECsCell Hoare distinct proteins called uroplakins, which along with
a collection of lipids, cholesterol, and sphingolipids, which
constitute a distinct cellular entity called lipid rafts, provide
a highly ordered lipid structure with very low membrane
fluidity and permeability (Apodaca, 2004; Truschel et al.,
2002). Another major impediment to bacterial colonization
is the powerful flushing actions of urine, which eliminate all
bacteria that are not intimately associated with BECs
(Reid and Sobel, 1987). In addition to these physical
barriers, prospective pathogens have to survive various
powerful antimicrobial actions initiated by BECs and other
mucosal cells (Mulvey et al., 2000; Samuelsson et al.,
2004). Present in the plasma membrane of the epithelial
cells are pattern recognition receptors (PRRs) such as
TLR4 that recognize lipopolysaccharide (LPS) on Gram-
negative bacteria and activate a sequence of intracellular
signals resulting in activation of the transcriptional factor,
NF-kB, and the production of several NF-kB-dependent
cytokines including chemoattractants that recruit phago-
cytic cells to clear the infection (Schilling et al., 2003;
Svanborg et al., 2006). The importance of TLR4 in the
innate immune response is evident from the findings that
TLR4 mutant mice mount a poor cytokine and neutrophil
response to urinary tract infections (UTIs). Consequently,
in contrast to isogenic control mice, these mice fail to
resolve their infections (Hagberg et al., 1984; Schilling
et al., 2001; Svanborg et al., 2006).
The TLR4 signaling mechanisms in BECs leading to cy-
tokine and neutrophil responses during UTIs now appear
to be more complex and distinct from those seen in other
cell types. Initial studies revealed a signaling cascade
consistent to that described in other cells, namely,
engagement of TLR4 by LPS triggers a signaling pathway
involving several intracytoplasmic and nuclear transcrip-
tional factors (Fischer et al., 2006; Schilling et al., 2001).
TLR4 activation first engages a set of adaptor family mem-
bers, which initiate a sequence of signaling events, result-
ing eventually in the activation of the transcriptional factor
NF-kB and the expression of several immunomodulatory
cytokines such as IL-6 and IL-8 (Kawai and Akira, 2006;
Schilling et al., 2001). More recent studies now reveal
that the vigorous and rapid TLR4 mediated IL-6 and IL-8
responses of BECs to UPEC is only partially attributable
to the classical NF-kB pathway and that a second and
more rapid signaling pathway is involved. This pathwayst & Microbe 1, 287–298, June 2007 ª2007 Elsevier Inc. 287
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messengers, Ca2+ and cAMP, as well as a transcriptional
factor cAMP response element binding protein (CREB)
(Song et al., 2007). Although this distinct TLR4-mediated
pathway appears to be present only in BECs (Song
et al., 2007), its specific contribution to bladder defense
is unknown.
Uropathogens that overcome the defenses of the uri-
nary tract typically do so by seeking refuge within the
bladder epithelium. In their intracellular location, these
pathogens avoid the clearing actions of both urine flow
and recruited phagocytes. The most common mode of
bacterial invasion of BECs involves type 1 fimbriae which
are filamentous appendages expressedbyE. coli,K. pneu-
moniae, and various other uropathogenic enterobacteria
(Abraham et al., 1988; Hagberg et al., 1983; Hagberg
et al., 1981). Binding of FimH, a mannose-binding lectin
at the distal tips of the fimbriae to uroplakin 1a on the
luminal surface of BECs, triggers a distinct series of signal-
ing reactions that culminates in the entry of the bacteria
into the dynamic subapical pool of discoid vesicles called
fusiformvesicles found inBECs (Bishopet al., 2007). These
fusiform vesicles are membrane-rich nondegradative
compartments that serve to increase bladder volume by
fusing with luminal plasma membrane of BECs (Truschel
et al., 2002). Since the plasma membrane of BECs as
well as fusiform vesicles are highly enriched in cholesterol,
sphingolipids, and glycolipids (Apodaca, 2004), there is
growing realization that UPEC invasion of BECs is lipid
raft dependent. This notion has been supported by the
finding that specific disruptors of cellular lipid raft structure
inhibit UPEC invasion, and key cellular components so far
implicated in bacterial invasion of BECs are typically local-
izedwith lipid raft structure (Duncan et al., 2004). One such
lipid raft mediator of bacterial invasion is the Rho GTPase
member, Rac-1, whose activation is critical because it
enhances accumulation of actin filaments at sites of bacte-
rial entry (Duncan et al., 2004; Martinez and Hultgren,
2002).
During infection of the urinary tract, both TLR4-
mediated signaling and lipid raft-mediated bacterial inva-
sion of BECs are believed to occur. Here, we reveal the
existence of crosstalk between the two pathways, where
TLR4 signaling through increased production of the
secondary messenger cAMP negatively regulates lipid
raft-mediated bacterial invasion.
RESULTS
Increased Invasion of Mouse Bladders by
Gram-Negative Bacteria When TLR4 Signaling
Is Abrogated
One of the earliest in vivo examples revealing the critical
role of PRRs in host defense was the observation made
over 20 years ago that TLR4 mutant C3H/HeJ mice, in
contrast to isogenic control C3H/HeN mice, were unable
to clear experimental UTIs (Hagberg et al., 1984; Shahin
et al., 1987). This observation was ascribed to the inability
of TLR4mutantmice tomount a local cytokine and neutro-288 Cell Host & Microbe 1, 287–298, June 2007 ª2007 Elsevierphil response (Hagberg et al., 1984; Shahin et al., 1987).
Here, we examined if, in addition to their inability to mount
an adequate inflammatory response, these TLR4 mutant
mice exhibited increased susceptibility to bacterial inva-
sion. A small volume (50 ml) of saline containing 1 3 108
of a type 1 fimbriated uropathogenic E. coli strain CI5
was introduced via catheter into the bladders of a group
of anesthetized TLR4 mutant and isogenic control mice.
One hour later, the bladders were emptied and instilled
with gentamicin for 30 min to kill all extracellular bacteria.
Thereafter, the mice were sacrificed and the bladders
were removed and rinsed, and the intracellular numbers
of bacteria were determined by standard colony counts
of bladder homogenates (Hagberg et al., 1984). The
values obtained from each bladder homogenate represent
the number of intracellular bacteria. Since the incubation
time was limited to only 1 hr, the contribution of recruited
immune cells to bacterial clearance was minimal. We
found that the number of intracellular E. coli in the blad-
ders of TLR4 mutant mice were at least 12-fold higher
than the controls (Figure 1A). Immunomicroscopy of
bladder cross-sections of both groups of mice confirmed
bacterial association with the superficial epithelium of the
bladders of TLR4 mutant but not in control mice (Figures
1B and 1C). Employing immunoprobes for TLR4, we
sought to confirm earlier claims of the presence of TLR4
in bladder cells (Backhed et al., 2001; Samuelsson et al.,
2004). Whereas no discernable staining was observed
when an isotype antibody was employed (Figure 1D), the
relatively large basal level of TLR4 expression on superfi-
cial BECs in control mice was striking (Figure 1E). Interest-
ingly, neither the distribution nor expression levels of TLR4
appeared to change following bacterial infection
(Figure 1F). To demonstrate the specificity of this TLR4-
mediated response for LPS, we examined the invasive
capacity of another LPS producing bacteria, a type 1 fim-
briated uropathogenic Klebsiella pneumoniae strain 1236,
as well as a non-LPS producer, a clinical isolate Staphylo-
coccus aureus strain 54.Whereas no significant difference
between the TLR4 mutant and control mice in staphylo-
coccal invasion was detected, an 11-fold difference in
invasion was observed with K. pneumoniae (Figures 1G
and 1H). These observations reveal that compared to con-
trols, TLR4 mutant mice are highly susceptible to invasion
by type 1 fimbriated Gram-negative enteric bacteria.
Thus, TLR4 markedly suppresses the invasion of BECs
by type 1 fimbriated enterobacteria.
To further support this conclusion, we compared the
ability of an LPS modified type 1 fimbriated K-12 E. coli
strain MLK1067 (msbB mutant) and its parent strain
W3110 (Clementz et al., 1997) to invade bladders of
wild-type mice. The msbB mutant E. coli MLK1067 pro-
duces a penta-acylated lipid A that is poorly recognized
by the TLR4 signaling complex and, as a consequence,
this strain fails to trigger TLR4-LPS signaling in host cells
(Coats et al., 2005). Predictably, unlike the parent strain,
the msbB mutant will not activate TLR4, and, therefore,
a significantly greater invasion of mouse bladders should
result. Indeed, we found a 6.3-fold greater invasion ofInc.
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(A) TLR4 mutant C3H/HeJ (HeJ) and isogenic control C3H/HeN (HeN) mice were inoculated transurethrally with 1 3 108 of E. coli CI5. Bacterial
invasion after 1 hr was assessed by gentamicin protection assays followed by colony counts of bladder homogenates.
(B andC) Fluorescent images of bladder sections of HeN (B) andHeJ (C)mice 1 hr following instillation of 13 108E. coliCI5. Green, E. coli; Red,Wheat
Germ Agglutinin (WGA).
(D–F) TLR4 immunostaining images of bladder sections of HeNmice before (D and E) and 1 hr after (F) instillation of 13 108 E. coliCI5. (E) and (F) were
stained with TLR4-specific antibody whereas (D) was stained with isotype control antibody.
(G and H) TLR4 mutant HeJ and control HeN mice were inoculated transurethrally with 1 3 108 of type 1 fimbriated K. pneumoniae 1236 (G), or
S. aureus 54 (H). Bacterial invasion after 1 hr was assessed as before.
(I) TLR4 mutant HeJ and control HeN mice were inoculated transurethrally with 1 3 108 of type 1 fimbriated msbB mutant MLK1067 (msbB-) or
correspondingwild-type (WT) E. coliW3110. Bacterial invasion after 1 hr was assessed as before. In (A), (G), (H), and (I), **p < 0.0001; *p < 0.01, relative
to values of HeN; #p < 0.05, relative to values of wild-type E. coliW3110 infected HeN. Error bars represent the mean + S.D. In (B)–(F), magnification
was 2003. L stands for lumen.mouse bladders by the mutant MLK1067 strain compared
to the parent strain (Figure 1I). Consistent with this idea,
when we compared bladder invasion by wild-type and
msbB mutant E. coli in the TLR4 mutant mice, no signifi-
cant difference in invasion between the two strains was
seen (Figure 1I). Cumulatively, these observations provide
definitive evidence that TLR4-LPS signaling plays a key
role in reducing bacterial invasion of bladder cells.
Recapitulation of In Vivo Observations Using
a Human BEC Line
To elucidate the molecular basis for TLR4-mediated abro-
gation of bacterial invasion, we initiated studies employing
a well-established in vitro model, the 5637 human BECCell Holine. It has previously been demonstrated that interactions
of this cell line with Gram-negative bacteria closely mimic
in vivo behavior of BECs (Duncan et al., 2004; Schilling
et al., 2001). We sought to recapitulate our in vivo obser-
vations of the modulatory role of TLR4 on E. coli invasion.
First, we compared invasion of BECs by wild-type E. coli
W3110 and its msbB mutant derivative, and observed
a 9-fold greater invasion by the mutant E. coli compared
to the parent E. coli strain (Figure 2A), which is consistent
with the in vivo data. Next, using RNA interference tech-
niques, we generated BECs where expression of TLR4
was knocked down (KD). Densitometric quantitation of
message levels in the TLR4 KD BECs revealed that the
expression of TLR4 was reduced by 49% (Figure 2B).st & Microbe 1, 287–298, June 2007 ª2007 Elsevier Inc. 289
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TLR4 Abrogates BEC Invasion by E. coliFigure 2. TLR4-LPS Signaling Abrogates
In Vitro Invasion of BECs by Type 1
Fimbriated Enterobacteria
(A) Bacterial invasion following exposure of
BECs to wild-type E. coli W3110 (WT) or
msbB mutant E. coli MLK1067 (msbB-). **p <
0.001, relative to values of wild-type E. coli
infected BECs.
(B) RT-PCR of control-transfected BECs
(Ctrl) and TLR4 knockdown BECs (TLR4 KD).
Glyseraldehyde-3-phosphate dehydrogenase
(GAPDH) was employed as a loading control.
(C and D) Bacterial invasion (C) or bacterial
adherence (D) following exposure of nontrans-
fected BECs (NT), control-transfected BECs
(Ctrl), and TLR4 KD BECs to type 1 fimbriated
E. coli ORN103(pSH2). *p < 0.03, relative
to control values. Error bars represent the
mean + S.D. in (A), (C) and (D).We sought to compare invasion of control (transfected
with control vector) BECs and TLR4 KD BECs by the
type 1 fimbriae expressing E. coli ORN103(pSH2). This
K-12 laboratory E. coli strain expressing recombinant
type 1 fimbriae rather than a UPEC strain was employed
for most of our subsequent studies (Orndorff and Falkow,
1984). Typically, in addition to type 1 fimbriae, UPEC ex-
press several other virulent factors that could potentially
confound our studies. As expected, we found that E. coli
ORN103(pSH2) invaded TLR4 KD BECs in significantly
higher numbers than control transfected or nontrans-
fected BECs (Figure 2C). It is noteworthy that the adher-
ence of E. coli to both control BECs and TLR4 KD BECs
were identical (Figure 2D). It is also noteworthy that inva-
sion of TLR4 KD BECs by E. coli ORN103(pSH2) was
also FimH-dependent because limited invasion of TLR4
KD BECs was observed when the isogenic FimH mutant
E. coli ORN103(pUT2002) (Minion et al., 1986) was tested
(data not shown). Thus, our in vitro data recapitulate our
in vivo observations implicating TLR4 as a negative mod-
ulator of E. coli invasion into BECs.
TLR4KDBECs Exhibit an Enhanced Rac-1 Response
to E. coli
To gain an understanding of how TLR4 signaling was
negatively impacting bacterial invasion in BECs, we
sought to compare the level of Rac-1 activation in TLR4
KD BECs and control BECs following exposure to type 1
fimbriated E. coli ORN103(pSH2). We and others have
previously implicated Rac-1, a critical mediator of actin
cytosketal dynamics and a component of lipid rafts, in
the invasion of BECs by E. coli (Duncan et al., 2004;
Martinez and Hultgren, 2002). Shown in Figure 3A is a
confirmatory experiment where invasion by type 1 fim-
briated E. coli ORN103(pSH2) of control BECs, BECs
overexpressing constitutively activated Rac1, and BECs
overexpressing a dominant negative form of Rac-1 was290 Cell Host & Microbe 1, 287–298, June 2007 ª2007 Elsevier Iexamined. Compared to control BECs, bacterial invasion
of BECs where Rac1 was constitutively activated was
markedly higher. Conversely, bacterial invasion of BECs
with the dominant-negative form of Rac-1 was signifi-
cantly lower than the controls (Figure 3A). Both of these
observations reiterate the idea that Rac-1 activation is
essential to the invasion of BECs by type 1 fimbriated
E. coli. To investigate the activation states of Rac-1 in
TLR4 KD BECs, nontransfected BECs and control trans-
fected BECs, we isolated activated Rac-1 from each of
the BEC lysates before and 30 min following exposure to
E. coli ORN103(pSH2). The assay we employed to detect
the activated form of Rac-1 was a pull-down assay em-
ploying a fusion protein comprising GST fused to PAK,
which specifically binds active GTP bound Rac-1 (Manser
et al., 1994). An appreciable increase in activated Rac-1
was detected in each of the cell types 30 min following
exposure to bacteria, although the amounts of activated
Rac-1 BECs in TLR4 KD BECs was markedly higher
than in any of the control BECs (Figure 3B). Indeed, the
level of activated Rac-1 in each cell type (Figure 3B) corre-
lated closely with the extent of bacterial invasion seen
(Figure 2). These observations suggest that TLR4-medi-
ated suppression of bacterial invasion is through inhibition
of Rac-1 activation. It is noteworthy that even before
exposure to bacteria, the levels of activated Rac-1 in
TLR4 KD BECs was relatively high (Figure 3B), suggesting
that TLR4 may be constitutively suppressing Rac-1 in
quiescent cells.
TLR4 KD BECs Evoke a Reduced cAMP Response
to E. coli
Since TLR4 has not previously been reported to suppress
activation of Rac-1, we reasoned that the mechanism
would involve one or more inhibitory intermediaries. Be-
cause secondary messengers can have profound and
sometimes inhibitory effects on multiple cellular functions,nc.
Cell Host & Microbe
TLR4 Abrogates BEC Invasion by E. coliwe examined the possibility of cAMP as the candidate
inhibitory substrate. cAMP has previously been shown to
negatively regulate Rac-1 activity and subsequent Rac-1
mediated reorganization of actin cytoskeleton (Nagasawa
et al., 2005). Rac-1 inactivation by cAMP has been shown
to specifically involve protein kinase A (PKA), whose cata-
lytic domains are activated by cAMP binding (Howe, 2004;
O’Connor and Mercurio, 2001; Waschke et al., 2004). Be-
fore determiningwhether cAMPwas involved in suppress-
ing Rac-1 activation, it was important to demonstrate
cAMP production by BECs following exposure to type 1
fimbriated E. coli ORN103(pSH2). We examined if this
was the case and if so, whether TLR4 KD BECs evoked
a diminished cAMP response. We compared the levels
of intracellular cAMP in control and TLR4 KD BECs before
and 1 hr after exposure to E. coli ORN103(pSH2). We ob-
served a marked increase in intracellular cAMP in BECs
Figure 3. TLR4 KD BECs Exhibit an Enhanced Rac-1
Response toE. coliwhich Correlateswith Enhanced Bacterial
Invasion
(A) Invasion of control-transfected BECs, BECs overexpressing con-
stritutively active Rac1, or BECs with dominant-negative Rac1 by
type 1 fimbriated E. coli ORN103(pSH2). **p < 0.01; *p < 0.05, relative
to control values. Error bars represent the mean + S.D.
(B) GTP-bound Rac1 levels of nontransfected (NT), control-
transfected (Ctrl), and TLR4 KD BECs before (0) and 30 min after (30)
exposure to E. coli. An actin-specific western blot was used as a load-
ing control.Cell Hfollowing exposure to bacteria (Figure 4A). This bacteria-
induced increase in intracellular cAMP was significantly
reduced in TLR4 KD BECs (Figure 4A) indicating that
TLR4 was mediating this cAMP response. A similar obser-
vationwasmade if theE. coliwas replaced by purified LPS
(Figure 4A), which is consistent with the notion that the
bacterial component responsible for activating TLR4
was indeed LPS. It should be noticed that bacteria-
induced increase in intracellular cAMP was seen as early
as 15 min after exposure, but the 1 hr time point was se-
lected so as to maximize difference in cAMP levels under
various conditions. To further investigate the relationship
between intracellular cAMP and E. coli invasion of BECs,
we compared bacterial entry into nontransfected, con-
trol-transfected, and TLR4 KD BECs following treatment
with 50 mM forskolin (Fsk), a broad spectrum activator of
adenylyl cyclases, or 1 mM dibutyryl cAMP (dbcAMP),
a membrane permeable cAMP analog. In all cases, Fsk
and dbcAMP treatments markedly reduced bacterial
uptake indicating that increasing intracellular cAMP levels
had a powerful effect in blocking E. coli invasion (Fig-
ure 4B).We next investigated if the Fsk-mediated increase
in intracellular cAMP would also negatively impact Rac-1
activation. We examined for bacterial induced Rac-1 acti-
vation in untreated and Fsk treated BECs. As shown in
Figure 4C, Fsk treated BECs failed to evoke any Rac-1
activation in response to bacteria which is consistent
with the finding that Fsk significantly reduces bacterial
invasion in BECs (Figure 4B). In additional experiments,
we compared the effects of two membrane-permeable
cAMP analogs, dbcAMP and 8-CPT-cAMP, on bacterial
invasion. Whereas the former analog activates two down-
stream effectors PKA and the exchange protein directly
activated by cAMP (Epac), the latter activates only Epac.
We found that dbcAMP but not 8-CPT-cAMP significantly
inhibited bacterial invasion (Figure 4D), indicating that
PKA but not Epac was involved in the uptake of bacteria.
Consistent with this notion, treatment of BECs with a PKA
specific inhibitor peptide (PKI) or another cell-permeable
cAMP analog, 6-Bnz-cAMP, which specifically activates
PKA, revealed negative impacts of cAMP-PKA on E. coli
invasion (Figure 4D). Thus, the enhanced levels of bacte-
rial invasion seen in TLR4 KD BECs compared to control
BECs are directly attributable to their limited cAMP
response to bacteria. Our observations cumulatively
support the notion that TLR4-mediated increase in intra-
cellular cAMP and its downstream effector, PKA, are
largely responsible for suppressing Rac-1-mediated
bacterial invasion.
The BEC cAMP Response to E. coli Is Mediated
by Adenylyl Cyclase 3
Next, we sought to determine how TLR4 was increasing
intracellular cAMP levels in BECs. Because there are
currently ten known isoforms of mammalian adenylyl
cyclases (ACs) (Sunahara and Taussig, 2002), it was of in-
terest to identify the specific AC in BECs responsible for
the TLR4-mediated cAMP response. First, we sought to
determine which AC isoforms were actually expressed inost & Microbe 1, 287–298, June 2007 ª2007 Elsevier Inc. 291
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TLR4 Abrogates BEC Invasion by E. coliFigure 4. TLR4 KD BECs Evoke a Reduced cAMP Response to E. coli which Correlates with Increased Bacterial Invasion
(A) Intracellular cAMP levels of control-transfected BECs (Ctrl) and TLR4 KD BECs after exposure to type 1 fimbriated E. coliORN103(pSH2) or E. coli
LPS. *p < 0.05 relative to E. coli (EC) or LPS-treated control.
(B) E. coli invasion of nontransfected (NT), control-transfected (Ctrl), and TLR4 KDBECs left untreated (UT) or following treatment with 50 mM forskolin
(Fsk) or 1 mM dibutryl cAMP (dbcAMP). *p < 0.001 relative to values of respective UT BECs.
(C) GTP-bound Rac1 levels in untreated (UT) and forskolin-treated (Fsk) BECs before (0) or after 30 min (30) exposure to E. coli. An actin-specific
western blot was used as a loading control.
(D) E. coli invasion of untreated (UT) BECs or BECs following 30 min treatment with 0.2 mM PKA inhibitor peptide (PKI), 1 mM dibutyryl cAMP
(dbcAMP), 1 mM 6-Bnz-cAMP, or 1 mM 8-CPT-2-cAMP. **p < 0.001; *p < 0.01, relative to UT values. Error bars represent the mean + S.D. in (A),
(B), and (D).BECs. RT-PCRwas performed on total cellular RNA, using
primers specific for each known AC isoforms, and only
mRNA for AC isoforms 3, 4, 6, and 7 was detectable in
BECs (Song et al., 2007) (data not shown). We confirmed
that the other AC isotype-specific primers usedwere func-
tional by undertaking RT-PCR on total RNA from human
embryonic kidney (HEK) cells, positive control cells, where
all ACs except AC4 and AC8 were expressed (Ludwig and
Seuwen, 2002) (data not shown). RNAi was utilized to
minimize the expression of each AC, which was verified
by AC isotype-specific RT-PCR (Figure 5A). To see which
of the four ACs were involved in suppressing E. coli inva-
sion, we exposed the respective KD BECs to E. coli
ORN103(pSH2) and examined for cAMP production and
bacterial invasion. We observed an increase in intracellu-
lar cAMP in all the KD cells except AC3 KD BECs
(Figure 5B). Similarly, the level of invasion into the various
BECs was comparable with that of the control except AC3
KD BECs following E. coli exposure (Figure 5C). Indeed,
the level of bacterial invasion in AC3 KD BECs was over
3-fold higher than in controls. Consistent with these find-
ings, there was a high level of Rac-1 activation in AC-3
KD BECs following exposure to E. coli ORN103(pSH2)
relative to controls (Figure 5D). Thus, AC3 is the BEC AC
isoform linked to the intracellular cAMP response follow-
ing E. coli exposure. This means that AC3 is also the iso-292 Cell Host & Microbe 1, 287–298, June 2007 ª2007 Elsevierform that is responsible for suppressing invasion of human
BECs by E. coli. The high level of Rac-1 activation seen in
quiescent AC-3 KD BECs is reminiscent of the situation in
TLR4 KD BECs and suggests that the suppressive effects
of TLR4 on Rac-1 activation in quiescent BECs is through
AC-3 derived cAMP.
Application of a Booster of Intracellular cAMP in the
Urinary Tracts of TLR4 Mutant Mice Reduces
Bacterial Invasion
In our in vivo studies, we had observed that TLR4 mutant
mice were highly susceptible to invasion by uropatho-
genic E. coli and K. pneumoniae (Figures 1A and 1B).
Our in vitro studies suggest the existence of a cAMP-
dependent innate mechanism in BECs for countering
bacterial invasion. We sought to establish a link between
intracellular cAMP in BECs and susceptibility to bacterial
invasion in vivo. Our in vitro studies have suggested that
if TLR4 constitutively regulates cAMP levels in BEC in
a positive fashion, intracellular levels of cAMP in TLR4
mice would predictably be lower than that seen in control
mice. We compared the basal cAMP levels in superficial
BECs of bladders in TLR4 mutant and control mice, and,
as predicted, intracellular cAMP levels in TLR4 mutant
mice were found to be significantly lower than in control
BECs (Figure 6A). Thus, the increased susceptibility ofInc.
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TLR4 Abrogates BEC Invasion by E. coliFigure 5. The BEC cAMP Response to
E. coli and Its Subsequent Effect on Bac-
terial Invasion Is Mediated by Adenylyl
Cyclase 3
(A) RT-PCR of control-transfected BECs (Ctrl)
and AC-3, -4, -6, or -7 KD BECs. GAPDH-spe-
cific RT-PCR was used as a loading control.
(B) Intracellular cAMP levels in nontransfected
BECs (NT), control-transfected BECs (Ctrl), or
AC3, -4, -6 or -7 KD BECs before (UT) or after
exposure to E. coli ORN103(pSH2) (EC). *p <
0.005 and **p < 0.02 relative to respective UT
values.
(C) E. coli invasion of control-transfected BECs
(Ctrl), or AC-3, -4, -6, or -7 KD BECs. **p <
0.0001 relative to control values. Error bars
represent the mean + S.D. in (B) and (C).
(D) Active-Rac1 levels of control and AC3 KD
BECs before and at 15 or 30min after exposure
to E. coli. An actin-specific western blot was
used as a loading control.TLR4mutant mice to enterobacterial invasion could be at-
tributable to low levels of intracellular cAMP in BECs. If the
increased susceptibility of TLR4 mutant mice to bacterial
invasion is attributable to their inability mount an appropri-
ate cAMP response, then application of the cAMP booster
Fsk should compensate for the cAMP deficiency and
reduce susceptibility to bacterial invasion. Indeed, when
bacterial invasion and intracellular cAMP levels in BECs
of TLR4 mutant mice were examined following combined
intraperitoneal/intravesicular Fsk treatment, the levels
were comparable to that seen in the wild-type mice (Fig-
ures 6A and 6B), indicating that the increased susceptibil-
ity could be reversed merely by treating the urinary tract
with a booster of intracellular cAMP levels. Application
of Fsk to TLR4 mutant mice also reduced invasion by
type 1 fimbriated K. pneumoniae 1236 but not invasion
by S. aureus 54 (Figures 6C and 6D).CellDISCUSSION
Invasion of host cells is the singular most important mech-
anism that pathogens employ to avoid rapid clearance by
the host’s immune system. Here, we report a novel host
cell adaptation for resisting this powerful microbial trait.
The mechanism in BECs for resisting invasion by type 1
fimbriated E. coli involves TLR4, an immune surveillance
molecule, which is well known for mobilizing a wide range
of innate immune responses against Gram-negative bac-
teria including secretion of critical proinflammatory medi-
ators and antimicrobial peptides (Saemann et al., 2005;
Samuelsson et al., 2004; Schilling et al., 2003; Shahin
et al., 1987). Blocking invasion of type 1 fimbriated enter-
obacteria represents a novel albeit surprising role for TLR4
considering that TLRs in macrophages have been impli-
cated in promoting bacterial uptake and subsequentFigure 6. Reduced Intracellular Levels of cAMP in BECs of TLR4 Mutant Mice and Use of Fsk to Enhance Resistance of BECs to
Invasion by Type 1 Fimbriated Enterobacteria
(A) Intracellular cAMP in superficial BECs obtained from control (HeN), TLR4 mutant (HeJ) mice, and TLR4 mutant mice treated with Fsk (HeJ + Fsk)
(n = 3–5). **p < 0.01, relative to HeN values as well as relative to HeJ + Fsk values.
(B–D) Invasion of bladders of control (HeN) mice, TLR4 mutant (HeJ) mice, and TLR4 mutant (HeJ) mice pretreated with Fsk by 13 108 of E. coli CI5
(B), K. pneumoniae 1236 (C), or S. aureus 54 (D). When indicated, the mice were pretreated for 1 hr with forskolin via intravesicular catheter instillation
and intraperitoneal (IP) injection. Error bars represent the mean + S.D. in (A)–(D). ##p < 0.001; #p < 0.01, relative to HeN values. **p < 0.01; *p < 0.03,
relative to HeJ values.Host & Microbe 1, 287–298, June 2007 ª2007 Elsevier Inc. 293
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Parallel Signaling Reactions Occurring in
BECs During Infection by Type 1 Fimbri-
ated Enterobacteria
Highlighted in the figure is the TLR4-initiated
and AC-3-, cAMP-, and PKA-dependent
signaling pathway that dissects with and
abrogates the lipid raft-mediated endocytic
pathway.phagosome maturation (Blander and Medzhitov, 2004,
2006; Ozinsky et al., 2000; Underhill and Gantner, 2004).
Invasion of BECs by type 1 fimbriated UPEC involves
a distinct, but poorly defined, endocytic pathway. What
is currently known regarding UPEC invasion of BECs is
that cellular lipid raft components are involved and that
the internalized bacteria are retainedwithin compartments
resembling fusiform vesicles of BECs (Bishop et al., 2007;
Duncan et al., 2004). A number of lipid raft components
have been shown to be necessary for invasion of BECs
by UPEC including Uroplakin 1a, the FimH receptor, cav-
eolin-1, a scaffolding protein, and Rac-1, an inducer of
cytoskeletal remodeling (Duncan et al., 2004; Martinez
and Hultgren, 2002). Interestingly, our studies reveal that
Rac-1 is also a molecular target of TLR4 signaling and
that Rac-1 represents the site where TLR4 signaling and
lipid raft-mediated phagocytosis intersect. Shown in Fig-
ure 7 is a diagrammatic depiction of how TLR4 signaling
converges with the bacterial invasion pathway.
The connection between TLR4 and Rac-1 was revealed
from the findings that the level of Rac-1 activation in TLR4
KD BECs was markedly higher relative to control BECs
even in the steady state (Figure 3B). Although the levels
of activated Rac-1 correspondingly increased in each
cell type following exposure to type 1 fimbriated E. coli,
the amounts in TLR4 KD BECs was strikingly higher com-
pared to that in control BECs (Figure 3B). Thus, TLR4 was
negatively impacting Rac-1 activation, a necessary step
for actin remodeling and bacterial invasion (Duncan
et al., 2004; Martinez and Hultgren, 2002). TLR4-mediated
suppression of Rac-1 appears to be the underlying basis
for why bacterial invasion in TLR4 KD BECs is several
fold higher than in control BECs (Figures 2 and 3). Since
previous reports in other cell types have shown that
TLR4 regulation of Rac-1 activity is of a positive nature294 Cell Host & Microbe 1, 287–298, June 2007 ª2007 Elsevier(Schmeck et al., 2006; Wissel et al., 2005; Zhang et al.,
2005), our finding is consistent with the notion that TLR4
signaling circuitry in BECs is more complex than in other
cell types.
Since TLR4 has not previously been reported to nega-
tively impact activation of Rac-1, TLR4-mediated sup-
pression of Rac-1 activity presumably involves a distinct
set of ancillary molecules. Our studies point to a second
messenger, cAMP, and its downstream element, PKA,
as critical intermediaries in the TLR4 circuitry responsible
for suppressing Rac-1 activation and subsequent bacte-
rial invasion. We showed that following ligation of TLR4,
cAMP, derived primarily from AC-3, played a critical role
in impeding bacterial invasion. That AC-3 generated
cAMP was critical for abrogating bacterial invasion was
evident from the finding that both Rac-1 activation and
bacterial invasion was markedly enhanced in the AC-3
KD BECs compared to control BECs. Indeed, the levels
of Rac-1 activation and bacterial invasion in AC-3 KD
BECs were comparable to the strikingly high levels ob-
served previously in TLR4 KD BECs. Interestingly, in addi-
tion to regulating cAMP and Rac-1 activity during Gram
negative infections, TLR4 appears to play a constitutive
role in regulating thesemolecules even in quiescent BECs.
Since inhibitors of the transcriptional factor NF-kB such
as MG-132 had limited effect on either intracellular pro-
duction of cAMP or bacterial invasion (data not shown),
these events appeared independent of the traditional
TLR4 signaling pathway. Recently, it was reported that
TLR4 activation in BECs resulted in signaling via the tradi-
tional NF-kB pathway as well as a second and a ‘‘more
rapid’’ pathway involving AC-3 derived cAMP and the
transcriptional factor, CREB (Song et al., 2007) (Figure 7).
That this TLR4 initiated and cAMP-dependent pathway
blocks bacterial invasion reveals an important andInc.
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pathway.
Presumably, the invasion-abrogating defenses in BECs
lining the lumen are triggered when TLR4 molecules make
contact with LPS shed from bacteria, an event likely to be
initiated as soon as bacteria enter the bladder. If the con-
taminating bacteria are not able to overcome cellular
actions that impede penetration, they will be rapidly
eliminated by the flushing forces of urine. That BECs are
invaded by type 1 fimbriated E. coli in spite of its TLR4me-
diated resistance argue that expression of type 1 fimbriae
could be a trait specifically evolved by UPEC to invade
BECs. Indeed a survey of UPEC isolates has revealed
that over 80% of UPEC expressed type 1 fimbriae (Hag-
berg et al., 1981; Langermann et al., 1997). The discovery
of the central role of cAMP in modulating cellular defenses
to bacterial invasion is also of particular interest because
intracellular cAMP levels are readily regulatable in vivo
with a variety of small molecule modulators (Elmslie,
2004; Insel and Ostrom, 2003; Pressman, 1976; Shafer
et al., 1998), raising the possibility of boosting bladder de-
fenses for therapeutic purposes. We have demonstrated
that administering TLR4 mutant mice with the cAMP in-
ducer, forskolin, can markedly boost both intracellular
cAMP levels and resistance of BECs to bacterial invasion
to levels typically found in wild-type cells. Recently, it was
reported that administering forskolin in the urinary tracts
of UPEC-infected mice reduced bladder infections by
triggering the exocytosis of UPEC from fusiform vesicles
of infected BECs (Bishop et al., 2007). Our findings sug-
gest that the protective properties ascribed to forskolin
in the urinary tract could also be attributable to reducing
bacterial invasion of BECs.
With the growing realization that most pathogens seek
refuge in host cells at some stage in the infectious pro-
cess, much of the research has focused on elucidating
the various strategies employed by pathogens to pene-
trate and subsequently survive within cells. The intrinsic
capacity of certain host cells to completely or partially
abrogate microbial entry has gone largely unrecognized.
Our studies demonstrating the intrinsic properties of
BECs to counter bacterial invasion could partly explain
the remarkable intractability of the urinary tract to infection
in spite of frequent contamination by gut flora.
EXPERIMENTAL PROCEDURES
In Vivo Invasion Assay
C3H/HeN and C3H/HeJ female mice were obtained from NCI and The
Jackson Laboratory. Eight- to ten-week-old female mice were anes-
thetized with sodium pentobarbital and inoculated transurethrally
with 1 3 108 of uropathogenic E. coli CI5 by urethral catheterization.
After 1 hr, 0.1 mg of gentamicin was applied for 30 min to kill all extra-
cellular bacteria, and bladders were washed briefly using 100 ml of
PBS. Bladders were aseptically removed and homogenized in 0.1%
Triton X-100 in PBS. Homogenate dilutions were plated on LB plates
and incubated overnight at 37C for colony counts. n = 10–20 per
each experimental group. When indicated, a group of mice were pre-
treated intraperitoneally with 10 mg/kg forskolin and transurethrally
with 100 mM forskolin for 1 hr. All experiments were done according
to protocols approved by the Duke Division of Laboratory AnimalCell HoResources and the Duke University Institutional Animal Care and
Use Committee.
Immunofluorescence of Bladder Sections
Eight- to ten-week-old female mice were anesthetized and inoculated
transurethrally with 1 3 108 of E. coli CI5. After 1 hr, bladders were
aseptically removed, embedded with OCT solution, and kept at
80C until use. Frozen sections of uninfected and infected bladders
were cut using standard methods. Each section was fixed in 4% para-
formaldehyde for 10 min at RT and in precooled ethanol:acetic acid
(2:1) for an additional 5 min at 20C, blocked in PBS with 3% BSA
for 30 min at RT, and incubated with primary antibodies diluted in
PBS with 3% BSA for 30 min at RT. Sections were incubated for 30
min at RT with Alexa 488 conjugated secondary antibodies diluted in
PBS with 1% BSA. To visualize epithelial cells, sections were incu-
bated with wheat germ agglutinin (WGA) for 30 min at RT when the
secondary antibodies were applied. Coverslips were mounted using
Prolong Gold anti-fade reagent (Molecular Probes) and viewed. For
TLR4 staining, sections were fixed as before, blocked in PBS contain-
ing 1% goat serum, and incubated with 1:100 diluted rat anti-mouse
TLR4 antibody (R&D Systems) in blocking solution overnight at 4C.
Same amounts of Rat IgG were used for the control staining. Sections
were incubated with FITC-conjugated secondary antibody for 30 min
at RT, mounted, and viewed.
Bacteria and Bladder Epithelial Cells
E. coli ORN103(pSH2) (Orndorff and Falkow, 1984), E. coli ORN103-
(pUT2002) (Minion et al., 1986), uropathogenic E. coli strain CI5 (Abra-
ham et al., 1985; Orndorff and Falkow, 1984; Thankavel et al., 1997),
E. coli MLK1067 (insertional inactivation mutant of msbB1) (Clementz
et al., 1997), E. coli W3110 (corresponding wild-type strain for
MLK1067) (Clementz et al., 1997), uropathogenic Klebsiella pneumo-
niae strain 1236 (a clinical isolate from Duke University Medical Cen-
ter), and a Gram-positive clinical isolate Staphylococcus aureus strain
54 (a clinical isolate from DUMC) were utilized in this study. Bacteria
were grown overnight in Luria-Bertani (LB) broth or in brain heart
infusion (BHI) broth prior to use. Eighty micrograms per milliliter of
chloramphenicol was added for E. coli ORN103(pSH2) and E. coli
MLK1067. The human bladder epithelial cell line 5637 (ATCC HTB-9)
was grown in RPMI 1640 (Invitrogen) containing 10% fetal bovine
serum (HyClone) and incubated at 37C with 5% CO2.
In Vitro Bacterial Invasion and Adherence Assays
5637 human BECs were seeded onto 96-well plates at a density of
4 3 104 cells/well and incubated overnight. The cells were infected
with 100 MOI bacteria for 1 hr. The medium was replaced with fresh
culture medium containing 100 mg/ml of the membrane-impermeable
antibiotic gentamicin (Invitrogen) to kill extracellular bacteria and incu-
bated at 37C for additional 1 hr. Each well was washed three times
with PBS. In order to lyse the cells, 100 ml of 0.1% Triton X-100 in
PBS was added to each well and incubated for 15 min. Cells were
scraped, diluted, and plated onto LB agar plates containing 80 mg/ml
of chloramphenicol. Colonies were counted to quantify the number
of invading bacteria. To test the effect of various drugs on bacterial in-
vasion, 50 mM forskolin (Sigma), 1 mM dibutyryl cAMP (Sigma), 1 mM
N6-Benzoyladenosine-30, 50-cyclic monophosphate (6-Bnz-cAMP,
Sigma), 1 mM 8-(4-Chlorophenylthio)-20-O-methyladenosine 30,50-
cyclic monophosphate (8-CPT-2-cAMP, Sigma), or 0.2 mM Protein
Kinase A inhibitor fragment (PKI, Sigma) in serum-free medium were
added to the cells for 30 min prior to infection. The viability of the cells
was not affected by any of the treatments used as determined by try-
pan blue exclusion. For theMTT adherence assay, cells were plated on
96-well plates, incubated overnight, and fixed for 15minwith 3%para-
formaldehyde. The monolayers were washed three times with sterile
PBS and pretreated for 1 hr at RT with blocking buffer (3% bovine
serum albumin in PBS). One-hundred microliters of E. coli strain
ORN103(pSH2) (A600 = 1.0) in PBS was incubated with cells for
1 hr at 37C. Nonadherent bacteria were removed by washing thest & Microbe 1, 287–298, June 2007 ª2007 Elsevier Inc. 295
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plied to each monolayer and incubated for 15 min at 37C. Fifty micro-
liters of 2 mg/ml MTT (Sigma) in PBS was added, and the plates were
incubated for 15 min at 37C to allow reduction of MTT to formazan by
live bacteria. Next, 150 ml of mixture of isopropyl alcohol and hydro-
chloric acid (24:1) was added to solubilize the formazan, and the
absorbance was measured at 450 nm using a Tecan Sunrise remote
microplate reader.
Creation of TLR4 Knockdowns Using RNA Interference
RNA interference vectors were generated using pQCXIN retroviral vec-
tor (BD Biosciences). Briefly, pQCXIN was digested by BamHI and
EcoRI and then was relegated to generate pQCXIN1. Human U6 small
nuclear RNA promoter was PCR-amplified from pTZ U6 + 1 (gift from
John Rossi, Beckman Research Institute of the City of Hope, Duarte,
CA) with added BglII site (50 ends), BamHI, and XbaI sites (30 ends).
The PCR product was cloned to the BglII and XbaI sites of pQCXIN1
to generate pQCXIN-U6. The following oligonucleotides were ordered
from Integrated DNA Technologies, Inc.: TLR4a, 50-GATCCGTTCCG
ATTAGCATACTTAGTTCAAGAGACTAAGTATGCTAATCGGAACTTTT
TTT-30, and TLR4b, 50-CTAGAAAAAAAGTTCCGATTAGCATACTTAG
TCTCTTGAACTAAGTATGCTAATCGGAACG-30. The italicized and
underlined sequences are forward and reverse sequences, respec-
tively, which correspond to nucleotides 1026–1044 of the human
TLR4 gene (GenBank accession number U88880). The oligos were an-
nealed to form double-stranded DNA and cloned into the BamHI and
XbaI sites of pQCXIN-U6 to generate pSi-TLR4. The Amphopack-
293 Cell Line (BD Biosciences) was used to produce the viral particles.
Production of viral particles, infection of target cell line (5637), and
selection of viral infected cells were performed as recommended by
the vendor of the pQCXIN vector (BD Biosciences). The geneticin-
resistant stable-transfected cell lines were named TLR4 KD BECs.
Knockdowns were verified by RT-PCR using the specific primers listed
below.
RNA Isolation and Reverse Transcription-Polymerase Chain
Reaction
Total cellular RNA was isolated using RNeasy purification system
(Qiagen). Two micrograms of total RNA was reverse transcribed and
amplified with gene-specific primers using the RT-PCR System kit
(Bio-rad). The primer sequences for the genes were as follows: 50-
CGATTCCATTGCTTCTTG-30 (sense) and 50-GCTCAGGTCCAGGT
TCTT-30 (antisense) for TLR4 and 50-ATCCCATCACCATCTTCCAG-30
(sense) and 50-CCTGCTTCACCACCTTCTTG-30 (antisense) for
GAPDH. The primer sequences for the AC genes and expected prod-
uct sizes were as summarized in Table S1 found in the Supplemental
Data available with this article online. We confirmed that the AC iso-
type-specific primers were functional by undertaking RT-PCR on total
RNA from HEK cells (a positive control cell, where all ACs except AC4
and AC8 were expressed) (Ludwig and Seuwen, 2002).
Creation of BECs Overexpressing Constitutively Activated
or Dominant-Negative Rac1
Rac1 was PCR amplified and inserted into the pLEGFP-C1 (Clontech)
to produce GFP-Rac1. The GFP-Rac1 construct was then used to
generate the dominant-active GFP-Rac1 (Q61L) or the dominant-
negative GFP-Rac1 (T17N) by using the QuikChange Site-Directed
Mutagenesis Kit (Stratagene) following the vendor’s instruction.
Rac1 Activity Assay
For Rac1 activity assay, we used a glutathione-S-transferase (GST)-
PAK-CD (p21-activated kinase [PAK] CRIB domain; which interacts
with activated form of Rac1) fusion protein to selectively isolate acti-
vated form of Rac1 from human BECs. Multiple steps were involved
in this approach; cloning and production of GST-PAK-CD fusion pro-
tein followed by pull down of activated form of Rac1 fromBEC extracts
employing the GST-PAK fusion protein.296 Cell Host & Microbe 1, 287–298, June 2007 ª2007 ElsevierCloning and Production of GST-PAK-CD Fusion Protein
We first generated a plasmid containing GST-PAK-CD as described
previously (Sander et al., 1998). Briefly, a DNA fragment encoding
amino acids 56–141 from human PAK1B (GenBank accession number
AF071884) was amplified by standard PCR and inserted into pGEX-
4T-1 (Amersham Pharmacia Biotech) to produce pGST-PAK-CD.
This plasmid was transformed into E. coli BL21. To purify GST-PAK-
CD protein, E. coli harboring pGST-PAK-CD were grown overnight in
LB broth with 100 mg/ml of ampicillin. On the following day, 1 ml of
grown bacteria was added into 20 ml LB broth with ampicillin, and in-
cubated for additional2 hr (A600 = 0.6–0.8). Expression of GST-PAK-
CD protein was induced by addition of 0.1 mM IPTG for another 4 hr.
Cells were harvested, resuspended in lysis buffer (0.1 M NaCl, 10 mM
Tris-Cl, pH 8.0, 1 mM EDTA, pH 8.0, 100 mg/ml lysozyme, 5 mM DTT,
protease inhibitor cocktail, 1.5% Sarkosyl), and then passed in 27G
needle ten times. The supernatant was taken and incubated with
50% Glutathione sepharose beads slurry (Amersham Pharmacia Bio-
tech) for 30 min at 4C. Fusion protein bound the beads washed and
directly used for a pull-down assay described as follows.
Pull Down and Quantitation of Activated Rac1
5637 human BECswere seeded onto 10-cm culture dish at a density of
4.23 106 cells/plate (60% confluency) and incubated overnight. The
mediumwas replacedwith fresh culturemediumwith 0.2%FBSand in-
cubatedat 37C for additional 5 hr. Thecellswere inoculatedwithE.coli
ORN103(pSH2) (100MOI), and incubated at 37C for experimental time
frames. The cells were lysed in a RIPA buffer (Upstate Biotechnology)
containing 1mMPMSF and a 1:100 dilution ofmammalian protease in-
hibitor cocktail (Sigma). The cell suspension was passed 20 times
through a 27G needle, and centrifuged for 5 min with the precipitates
then being discarded. Protein concentrations were determined using
the Bradford reagent (Bio-Rad) with bovine serum albumin as a stan-
dard. Topull downanactivated formofRac1 fromBECextracts, 200mg
BEC extracts were mixed with purified GST-PAK-CD protein bound
beads. Themixture was incubated for 1 hr at 4Cwith shaking, and pel-
letswere collected by centrifugation andwashed four timeswith 1ml of
lysis buffer. After final wash, 50 ml of 23 Sample buffer (Bio-Rad) was
added and the samples were boiled for 5 min. Western blotting for
Rac1 (BD Biosciences) was performed using 10 ml of the samples.
Measurement of Intracellular cAMP Levels
5637 human BECs were seeded onto 6-well plates and grown over-
night. The cells were uninfected or infected with 100 MOI E. coli
ORN103(pSH2), or treated with 100 mg/ml E. coli LPS (Sigma) for indi-
cated time points. The cells were washed four times with PBS to re-
move culture media and lysed in 250 ml of 0.1 M HCl for 10 min. After
centrifugation, the supernatant was directly used for the cAMP assay.
Intracellular concentrations of cAMP were determined using a cAMP
enzyme immunoassay kit (Sigma) according to the manufacturer’s in-
structions. In order to measure intracellular cAMP levels of BECs ob-
tained from control HeN and TLR4 mutant HeJ mice, 8- to 10-week-
old female mice were anesthetized and sacrificed, and bladders
were aseptically removed, bisected, turned epithelium-side out, and
lysed in 300 ml of 0.1MHCl for 20min. Supernatant from centrifugation
was directly used for the assay as before.
Statistics
Two tailed Student’s T-tests were performed in order to determine the
statistical significance of experimental changes from control values.
Supplemental Data
The Supplemental Data include one supplemental table and can be
found with this article online at http://www.cellhostandmicrobe.com/
cgi/content/full/1/4/287/DC1/.
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